The epidermal growth factor receptor: a new target for anticancer therapy

Curr Probl Cancer. 2002 May-Jun;26(3):109-64. doi: 10.1067/mcn.2002.125874.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / immunology*
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / drug effects*
  • ErbB Receptors / immunology
  • ErbB Receptors / physiology
  • Erlotinib Hydrochloride
  • Gefitinib
  • Humans
  • Morpholines / therapeutic use
  • Quinazolines / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Morpholines
  • Quinazolines
  • Canertinib
  • Erlotinib Hydrochloride
  • ErbB Receptors
  • Gefitinib